Heterogeneity of Colorectal Cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology

BACKGROUND: New drugs targeting specific genes required for unregulated growth and metastases have improved survival rates for patients with metastatic colorectal cancer. Resistance to monoclonal antibodies specific for the epidermal growth factor receptor (EGFR) has been attributed to the presence...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Perez, K, Walsh, R, Brilliant, K, Noble, L, Yakerivich, E, Breese, V, Jackson, C, Chatterjee, D, Pricolo, V, Roth, L, Shah, N, Cataldo, T, Safran, H, Hixson, D, Quesenberry, P
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4015467/
https://ncbi.nlm.nih.gov/pubmed/23528430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yexmp.2013.01.004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares